Physician profile
Patrick Daniel Fitzsimmons
NPI 1215496484
$5,650.02
in general payments reported to CMS, 2019-2025
14 companies · $458 in 2025
The $458 reported for 2025 was more than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $131 · 2023: $3,791 · 2024: $1,270 · 2025: $458.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,235 · Travel and Lodging: $1,150 · Education: $1,135.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,234.59 |
| Travel and Lodging | $1,149.81 |
| Education | $1,134.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $2,116.07 | 2023-2024 | Senza |
| Boston Scientific Corporation | $1,854.80 | 2023-2025 | Wavewriter Alpha Prime 16, Intracept, General - Therapies |
| Medtronic, INC. | $417.32 | 2023-2025 | Kyphon Express II Kyphopak Tray, Osteocool Rf Ablation System, Intellis Adaptivestim |
| Stryker Corporation | $341.48 | 2023-2024 | Spinejack |
| Avanos Medical | $273.44 | 2023-2025 | Generator, Coolief* Cooled Radiofrequency, Standard Rf Disposables |
| Curonix LLC | $268.34 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Averitas Pharma INC. | $122.10 | 2024 | Qutenza |
| Merz Pharmaceuticals, LLC | $109.00 | 2022-2025 | Xeomin |
| Spinal Simplicity, LLC | $34.13 | 2024 | Ha Minuteman G3-R |
| Saluda Medical Americas, INC. | $29.19 | 2024 | Evoke |
| Abbvie INC. | $28.00 | 2022 | |
| Spr Therapeutics, INC | $23.26 | 2022 | |
| Hydrocision, INC. | $19.54 | 2025 | Tenjet |
| Pfizer INC. | $13.35 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Fitzsimmons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.